Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.

Transfusion - 1 Nov 2002

Galel Susan A, Strong D Michael, Tegtmeier Gary E, Holland Paul V, Kuramoto Isamu K, Kemper Marti, Pietrelli Larry, Gallarda James

Abstract excerpt

BACKGROUND: Two HCV antibody tests (EIA 2.0 [EIA2], Abbott; and the Version 3.0 ELISA [EIA3], Ortho) are currently licensed for screening of US blood donors. Testing of donors for HCV RNA allows comparison of the sensitivities of the two antibody-screening assays. STUDY DESIGN AND METHODS: All allogeneic blood donations at 13 US test sites were screened for HCV RNA by testing plasma minipools using an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Blood Donors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C Antibodies

Share to Immunoblotting

Share to Immunoenzyme Techniques

Share to Mass Screening

Share to Seroepidemiologic Studies

Share to Viremia

Source

Identifiers

PMID: 12421226
DOI: 10.1046/j.1537-2995.2002.00236.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.PMID 12421226Read ↗

Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors.Semantic proximity Read ↗

Hepatitis C virus (HCV)-specific T-cell responses among recombinant immunoblot assay-3-indeterminate blood donors: a confirmatory evidence of HCV exposure.Semantic proximity Read ↗

Relevance of RIBA-3 supplementary test to HCV PCR positivity and genotypes for HCV confirmation of blood donors.Semantic proximity Read ↗

Prevalence of hepatitis C virus and genotype distribution in an Australian volunteer blood donor population.Semantic proximity Read ↗

Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification TestingSemantic proximity Read ↗

Evaluation of hepatitis C antibody testing in saliva specimens collected by two different systems in comparison with HCV antibody and HCV RNA in serum.Semantic proximity Read ↗

Sensitivity of HCV RNA and HIV RNA blood screening assays.Semantic proximity Read ↗

PRISM hepatitis B surface antigen detection of hepatits B virus minipool nucleic acid testing yield samples.Semantic proximity Read ↗

The immunoreactivity profile of different HCV genotypes on immunoblot assay and its implications in the development of diagnostic assays.Semantic proximity Read ↗

Simultaneous extraction of hepatitis C virus (HCV), hepatitis B virus, and HIV-1 from plasma and detection of HCV RNA by a reverse transcriptase-polymerase chain reaction assay designed for screening pooled units of donated blood.Semantic proximity Read ↗

Nucleic acid testing to detect HBV infection in blood donors.Semantic proximity Read ↗

Utilization of hepatitis C antibody-positive livers: genotype dominance is virally determined.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.